Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/27896| Title: | Secukinumab Provides Sustained Improvements in the Signs and Symptoms in Psoriatic Arthritis: Final 5 Year Efficacy and Safety Results from a Phase 3 Trial | Authors: | Mease, Philip J. Kavanaugh, Arthur Reimold, Andreas Tahir, Hasan Rech, Juergen Hall, Stephen GEUSENS, Piet Pascale, Pellet Delicha, Evie Maria Pricop, Luminita Mpofu, Shephard |
Issue Date: | 2018 | Publisher: | WILEY | Source: | ARTHRITIS & RHEUMATOLOGY, 70 (S9), (Art N° 2568) | Notes: | [Mease, Philip J.] Swedish Med Ctr, Seattle, WA USA. [Mease, Philip J.] Univ Washington, Sch Med, Seattle, WA USA. [Kavanaugh, Arthur] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA. [Reimold, Andreas] Hosp Southern Norway, Kristiansand, Norway. [Tahir, Hasan] Barts Hlth NHS Trust, Rheumatol, London, England. [Rech, Juergen] Univ Klinikum Erlangen, Erlangen, Germany. [Hall, Stephen] Monash Univ, Melbourne, Vic, Australia. [Geusens, Piet] Univ Hasselt, Hasselt, Belgium. [Geusens, Piet] Maastricht Univ Hosp, Maastricht, Netherlands. [Delicha, Evie Maria; Mpofu, Shephard] Novartis Pharma AG, Basel, Switzerland. [Pricop, Luminita] Novartis Pharmaceut, E Hanover, NJ USA. | Document URI: | http://hdl.handle.net/1942/27896 | ISSN: | 2326-5191 | e-ISSN: | 2326-5205 | ISI #: | 000447268904301 | Category: | M | Type: | Journal Contribution |
| Appears in Collections: | Research publications |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| 2568 2018-Arthritis_&_Rheumatology (2).pdf Restricted Access | Published version | 107.97 kB | Adobe PDF | View/Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.